论文部分内容阅读
我国应该探索建立政府宏观管理,专业机构组织实施,学术自治,学术同行评价的现代科研管理体制,而不是还把科研创新的希望寄托在“举国体制”。北京时间10月5日傍晚,84岁高龄的中国科学家屠呦呦荣获诺贝尔生理学或医学奖。这是屠呦呦继2011年荣获拉斯克奖后,再次荣获医学领域顶级奖项。屠呦呦的贡献是在上世纪七、八十年代创制新型抗疟药——青蒿素和双氢青蒿素,挽救了无数被疟疾折磨的病患。诺委会在新闻发布会上表示,“屠呦呦获诺奖并非是对中药的奖励,而是为了表彰她在受到中药的启发下对一种药物的寻找过
Our country should explore the establishment of a modern scientific research management system of government macroeconomic management, organization and implementation of professional institutions, academic autonomy, and academic peer review instead of pinning the hope of scientific research and innovation on the ”nationwide system.“ Beijing October 5 evening, 84-year-old Chinese scientist Tu Yo Yo won the Nobel Prize in Physiology or Medicine. This is Tu Yo-yo's top medical award again after winning the Lasker Award in 2011. Tu Yo-Yo's contribution was the creation of new anti-malarial drugs, artemisinin and dihydroartemisinin, in the 1970s and 1980s, saving millions of people suffering from malaria. Connaught Committee said at a news conference, ”Tu Yo Yo Nobel Prize is not a reward for Chinese medicine, but in recognition of her under the inspiration of Chinese medicine to find a drug